Salus reports lower H1 profit on higher revenue

Ljubljana – Salus, the Ljubljana-based pharmaceutical wholesaler, generated EUR 247 million in sales revenue in the first half of the year, an increase of 14% on the same period a year ago. Net profit was down by 13% to EUR 6.4 million, which the company linked to a successfully settled lawsuit against a pharmacy in receivership. According to a regulatory filing with the Ljubljana Stock Exchange on Friday, Salus saw its group net profit from regular operations drop to EUR 7.9 million in the January-June period this year from EUR…

For FREE further reading please JUST enter your email address

I allow to collect my email data for analytics and email campaign

The post Salus reports lower H1 profit on higher revenue appeared first on Slovenia Times.

Continue reading on: